Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2026-07-02 16:16:12 ET · period of report 2026-06-30 · accession 0001437749-26-022511 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:16 | 2026-06-30 | BKYI | LACOUS MIRA K | CTO | A - Grant | $3.83 | +250 | 4,076 | +7% | +$957.50 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | A | A | 250 | $3.83 | 4,076 | D | — | — | (F1) Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). (F2) All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026. |